$14.3 M

Avadim Health Revenue Q3, 2019
Avadim Health Gross profit (Q3, 2019)7.6 M
Avadim Health Gross profit margin (Q3, 2019), %53.2%
Avadim Health Net income (Q3, 2019)-10 M
Avadim Health Cash, 30-Sept-20197.2 M

Avadim Health Revenue

Avadim Health revenue was $29.04 m in FY, 2018 which is a 168.5% year over year increase from the previous period.

Embed Graph

Avadim Health Funding

Summary Metrics

Founding Date

2007

Avadim Health Revenue Breakdown

Embed Graph

Avadim Health revenue breakdown by business segment: 5.9% from Other , 39.9% from Institutional Care and 54.2% from Retail Pharmacy / Consumer

Avadim Health Income Statement

Annual

USDFY, 2017FY, 2018

Revenue

10.8m29.0m

Revenue growth, %

168%

Cost of goods sold

8.6m13.1m

Gross profit

2.3m16.0m

Gross profit Margin, %

21%55%

Sales and marketing expense

19.2m33.8m

R&D expense

1.7m1.9m

General and administrative expense

10.4m11.5m

Operating expense total

31.3m47.2m

EBIT

(29.1m)(31.3m)

EBIT margin, %

(269%)(108%)

Interest expense

153.6k17.8m

Interest income

76.0k

Net Income

(29.2m)(49.5m)

Avadim Health Balance Sheet

Annual

USDFY, 2017FY, 2018

Cash

2.9m17.4m

Accounts Receivable

2.0m3.4m

Prepaid Expenses

365.5k129.1k

Inventories

2.8m7.6m

Current Assets

10.1m28.6m

PP&E

3.5m4.3m

Total Assets

15.3m33.4m

Accounts Payable

3.3m5.1m

Short-term debt

698.7k42.4m

Current Liabilities

9.8m51.6m

Long-term debt

1.1m1.1m

Non-Current Liabilities

1.1m13.2m

Total Debt

1.8m43.5m

Total Liabilities

10.9m64.8m

Common Stock

61.9k66.1k

Additional Paid-in Capital

66.0m81.9m

Retained Earnings

(61.6m)(113.4m)

Total Equity

4.4m(31.4m)

Debt to Equity Ratio

0.4 x-1.4 x

Debt to Assets Ratio

0.1 x1.3 x

Financial Leverage

3.5 x-1.1 x

Quarterly

USDQ3, 2019

Cash

7.2m

Accounts Receivable

5.4m

Prepaid Expenses

159.1k

Inventories

12.4m

Current Assets

25.2m

PP&E

4.9m

Total Assets

32.8m

Accounts Payable

7.7m

Short-term debt

56.5m

Current Liabilities

69.4m

Long-term debt

1.1m

Non-Current Liabilities

14.6m

Total Debt

57.7m

Total Liabilities

84.0m

Common Stock

67.8k

Additional Paid-in Capital

93.9m

Retained Earnings

(145.2m)

Total Equity

(51.2m)

Debt to Equity Ratio

-1.1 x

Debt to Assets Ratio

1.8 x

Financial Leverage

-0.6 x

Avadim Health Cash Flow

Annual

USDFY, 2017FY, 2018

Net Income

(29.2m)(49.5m)

Depreciation and Amortization

2.2m1.8m

Accounts Receivable

(1.1m)(1.4m)

Inventories

(411.2k)(4.8m)

Accounts Payable

1.2m1.8m

Cash From Operating Activities

(18.3m)(31.2m)

Purchases of PP&E

(723.6k)(198.4k)

Cash From Investing Activities

(765.3k)(346.9k)

Long-term Borrowings

(435.7k)(11.7m)

Cash From Financing Activities

16.3m44.0m

Net Change in Cash

(2.8m)12.5m

Interest Paid

151.9k769.0k

Quarterly

USDQ3, 2018Q3, 2019

Net Income

(24.9m)(31.8m)

Depreciation and Amortization

1.5m934.0k

Accounts Receivable

(966.7k)(2.0m)

Inventories

(4.3m)(4.8m)

Accounts Payable

2.9m2.5m

Cash From Operating Activities

(21.9m)(20.0m)

Purchases of PP&E

(395.9k)(361.4k)

Cash From Investing Activities

(532.1k)(924.0k)

Long-term Borrowings

(1.3m)(1.6m)

Cash From Financing Activities

19.9m10.6m

Net Change in Cash

(2.5m)(10.3m)

Interest Paid

585.2k288.4k

Avadim Health Ratios

USDY, 2019

Revenue/Employee

63.3k

Debt/Equity

-1.1 x

Debt/Assets

1.8 x

Financial Leverage

-0.6 x

Avadim Health Operating Metrics

Jul, 2016Sep, 2019Nov, 2019Jan, 2020

Selling Points (Pharmacies)

47 k

Institutional Customers (Acute Care Hospitals)

60 250

Institutional Customers (Long-Term Care Facilities)

100 750

Completed Clinical Studies to Date

40

Products

6

Patents (US)

2

Patents Pending (US)

3

Patents (Foreign)

3

Patents Pending (Foreign)

20

Avadim Health Employee Rating

3.420 votes
Culture & Values
4.1
Work/Life Balance
4.2
Senior Management
3.5
Salary & Benefits
3.3
Career Opportunities
3.4
Source